Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 在庫あり | ¥ 11,500 |
10 mg | 在庫あり | ¥ 18,500 |
25 mg | 在庫あり | ¥ 36,000 |
50 mg | お問い合わせ | ¥ 66,500 |
100 mg | お問い合わせ | ¥ 103,000 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 15,500 |
説明 | Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively. |
ターゲット&IC50 | M3Dq (human):6.3 nM(Ki), M4Di (human):4.2 nM(Ki) |
分子量 | 292.38 |
分子式 | C18H20N4 |
CAS No. | 1977-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (342.02 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Deschloroclozapine 1977-07-7 Neuroscience Serotonin Transporter inhibit Inhibitor Muscarinic acetylcholine receptor hM4Di hM3Dq muscarinic-based mAChR DREADDs inhibitor